| Amanda Phelps, MS CCC-SLP | |
|
315 6th St S, Oneonta, AL 35121-1828 | |
| (205) 478-7065 | |
| Not Available |
| Full Name | Amanda Phelps |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 315 6th St S, Oneonta, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912364415 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3700 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Phelps, MS CCC-SLP 315 6th St S, Oneonta, AL 35121-1828 Ph: (205) 478-7065 | Amanda Phelps, MS CCC-SLP 315 6th St S, Oneonta, AL 35121-1828 Ph: (205) 478-7065 |
News Archive
Community Health Systems, Inc. announced today that a subsidiary of the Company has merged operations with Diagnostic Clinic of Longview, P.A., a large multi-specialty clinic serving residents of Longview, Texas, and surrounding East Texas communities.
The link between obesity and the risk of endometrial cancer has been well documented. A new study, however, shows that an even lower body mass index (BMI) than previously thought can signal an increased risk in Asian women with postmenopausal bleeding. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).
Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.
New research from Washington University School of Medicine in St. Louis suggests cooling the brain may prevent the death of nerve cells that has been observed in infant mice exposed to anesthesia.
The Belgian biotechnology company, Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiac diseases, today announces it has received authorization from the Belgian Federal Agency for Medicines and Health Products (FAMHP) to begin its Congestive Heart failure Cardiopoietic Regenerative Therapy (CHART-1) European Phase III trial for C3BS-CQR-1 in Belgium.
› Verified 8 days ago
Kaleigh Hyatt, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 6th St S, Oneonta, AL 35121 Phone: 205-274-2244 | |
Ms. Caroline Richelle Parker, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 6th St S, Oneonta, AL 35121 Phone: 205-274-2244 | |
Joshua Kendal Hubbard, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 212 Ellen St, Oneonta, AL 35121 Phone: 205-625-3520 | |
Mrs. Leah Shae Ganus, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 6th St S, Oneonta, AL 35121 Phone: 205-478-2244 | |
Phyllis Shirley, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 6th St S, Oneonta, AL 35121 Phone: 205-274-2244 | |
Elinor Clay Anthony, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 6th St S, Oneonta, AL 35121 Phone: 205-274-2244 | |
Abbey Oliver, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 6th St S, Oneonta, AL 35121 Phone: 205-274-2244 |